Arnold Dodderer - 16 Dec 2021 Form 4 Insider Report for Sunoco LP (SUN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Dec 2021, 16:00:18 UTC
Prior SEC filing
07 Dec 2021
Next SEC filing
07 Dec 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Peggy J. Harrison, Attorney-in-Fact for Mr. Dodderer

Key filing fact

Arnold Dodderer filed Form 4 for Sunoco LP (SUN) on 20 Dec 2021.

Key facts

  • This page summarizes Arnold Dodderer's Form 4 filing for Sunoco LP (SUN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Dec 2021, 16:00.

Change

  • Previous filing in this sequence was filed on 07 Dec 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SUN transaction

Common Units

Award

Transaction value
$0
Shares
+14,700
Change %
+22%
Price
$0.000000
Shares after
82,175
Date
16 Dec 2021
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Grant of restricted phantom units awarded under the terms of the Sunoco LP 2018 Long-Term Incentive Plan that will vest 60% on 12/5/2024 and 40% on 12/5/2026 generally contingent upon the continued employment of the reporting person on each applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .